Freedom (FRHC) had the highest return between 2017 and 2018 by a mid-cap US stock, returning 5,907.3%.
| ASSET | YEARS | % RETURN |
|---|---|---|
Freedom (FRHC) | 2017-2018 | 5,907.27% |
Arrowhead Pharmaceuticals (ARWR) | 2017-2018 | 696.15% |
Madrigal Pharmaceuticals (MDGL) | 2017-2018 | 653.98% |
Viking Therapeutics (VKTX) | 2017-2018 | 537.5% |
Vericel Corp Ord (VCEL) | 2017-2018 | 470.49% |
Enphase Energy (ENPH) | 2017-2018 | 363.73% |
EXACT Sciences (EXAS) | 2017-2018 | 363.63% |
Novocure (NVCR) | 2017-2018 | 321.13% |
Etsy (ETSY) | 2017-2018 | 297.41% |
Ringcentral (RNG) | 2017-2018 | 292.57% |
PAR Technology (PAR) | 2017-2018 | 289.09% |
RH (RH) | 2017-2018 | 289.03% |
Crocs (CROX) | 2017-2018 | 273.28% |
Option Care Health (OPCH) | 2017-2018 | 227.52% |
Freshpet (FRPT) | 2017-2018 | 215.29% |
Ascendis Pharma A-S (ASND) | 2017-2018 | 213.72% |
PTC Therapeutics (PTCT) | 2017-2018 | 210.31% |
Autohome (ATHM) | 2017-2018 | 210.07% |
Five9 (FIVN) | 2017-2018 | 205.09% |
Novanta (NOVT) | 2017-2018 | 196.47% |
Warrior Met Coal (HCC) | 2017-2018 | 185.16% |
IAC (IAC) | 2017-2018 | 179.88% |
Amedisys (AMED) | 2017-2018 | 173.3% |
Insperity (NSP) | 2017-2018 | 171.49% |
Planet Fitness (PLNT) | 2017-2018 | 163.36% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
